NCT00685685View on ClinicalTrials.gov

Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Lovastatin 40 mg tablets

40 mg tablet administered after an overnight fast of at least 10 hours

DRUG

Lovastatin (Mevacor®) 40 mg Tablets

40 mg tablet administered after an overnight fast of at least 10 hours

Trial Locations (1)

H7V 4B4

Algorithme Pharma, Montreal

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00685685 - Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets | Biotech Hunter | Biotech Hunter